When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 10 Hits
  • Search Condition : Filter (MeSH = Receptor, ErbB-2 / antagonists & inhibitors*)
Species Resource Title
Human and Animal Cells CW-2(RCB0778) , MKN-7(RCB3687) Engineering an anti-HER2 biparatopic antibody with a multimodal mechanism of action.
Human and Animal Cells HuCCT1(RCB1960) , TFK-1(RCB2537) Therapeutic implication of HER2 in advanced biliary tract cancer.
Human and Animal Cells MCF7(RCB1904) , A549(RCB0098) Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors.
Human and Animal Cells CW-2(RCB0778) Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity.
Human and Animal Cells ECC10(RCB0983) , GCIY(RCB0555) , MKN7(RCB0999) Antitumor activity of pan-HER inhibitors in HER2-positive gastric cancer.
Human and Animal Cells Ba/F3(RCB0805) Activity of a novel HER2 inhibitor, poziotinib, for HER2 exon 20 mutations in lung cancer and mechanism of acquired resistance: An in vitro study.
Human and Animal Cells HeLa(RCB0007) Construction of Anti-HER2 Recombinants as Targeting Modules for a Drug-delivery System Against HER2-positive Cells.
Human and Animal Cells CW-2(RCB0778) Overcoming resistance to HER2 inhibitors through state-specific kinase binding.
Human and Animal Cells MRC-5 Novel HER2 selective tyrosine kinase inhibitor, TAK-165, inhibits bladder, kidney and androgen-independent prostate cancer in vitro and in vivo.
Human and Animal Cells TGBC1TKB(RCB1129) Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas.